FDA panel backs Lilly’s Alzheimer’s drug; agency approves Ipsen’s med to treat rare liver disease
The US Food and Drug Administration’s (FDA) advisory committee has voted unanimously in favor of the benefits of Eli Lill...
Impressions : 1215
Vertex’s non-opioid painkiller succeeds in late-stage trials, FDA finalizes CAR-T guidance
In Phispers this week, there is news of an experimental
non-opioid painkiller from Vertex Pharmaceuticals showing positive res...
Impressions : 1252
BMS buys Karuna for US$ 14 billion; Astra-Ionis’ nerve damage drug bags FDA nod
This week’s Phispers is a double bill with news from last week and the first days of the New Year. Bristol Myers Squibb (...
Impressions : 2486
Teva indicted for fueling opioid addiction in NY; Theranos founder pronounced guilty for duping investors
In this first Phispers of 2022, we bring you several
updates on court cases involving pharmaceutical companies such as Teva,
...
Impressions : 1464
Pfizer’s oral Covid drug bags authorization in US; Biogen slashes price of its Alzheimer’s drug by half
In this week’s Phispers, we bring you updates on Biogen’s controversial Alzheimer’s drug, Novartis’ pla...
Impressions : 1888
Pfizer’s Covid-19 pill retains 89 percent efficacy, works on Omicron; CSL buys Vifor for US$ 11.7 billion
In
this week’s Phispers, we bring you news on several M&As and tie-ups along with updates on Covid-19 medications an...
Impressions : 1661
Drugmakers test vaccine efficacy against Omicron; FDA panel recommends Merck’s antiviral despite safety concerns
In this week’s Phispers, we bring you updates on the new Covid-19 variant – Omicron – and how vaccine makers ...
Impressions : 1874
Novartis may have a buyer for Sandoz; FDA suggests alternative approaches to assess nitrosamine risk
This week, Phispers brings you news on M&As, Covid
vaccines, lawsuits, regulations and more. Pfizer is expected to cross U...
Impressions : 2555
J&J to spin off consumer biz within two years; Biden nominates Califf as FDA chief
After a gap of a week, Phispers is back with reports of some big developments in the world of pharmaceuticals. The biggest news...
Impressions : 1862
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.